Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENACT: Venalot vs Placebo in Chronic Venous Insufficiency
NCT01848210Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in chronic venous insufficiency (CVI) comparing Venalot with Placebo (2 arms). Primary endpoint: Mean Change (Reduction) From Baseline in Volume of Reference Leg at 16 weeks. Started May 2013; status: completed.
02
Drugs
coumarin + troxerutin
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT01848210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848210.